Cytomx Therapeutics Inc buy BiotechBee
Start price
06.02.23
/
60%
€2.59
Target price
31.12.25
€4.00
Performance (%)
-40.15%
End price
05.05.23
€1.55
Summary
This prediction ended on 05.05.23 with a price of €1.55. The BUY prediction by BiotechBee for Cytomx Therapeutics Inc performed very badly with a performance of -40.15%. BiotechBee has a follow-up prediction for Cytomx Therapeutics Inc where he still thinks Cytomx Therapeutics Inc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cytomx Therapeutics Inc | -9.441% | -9.441% | -19.026% |
iShares Core DAX® | -3.935% | -3.998% | 11.192% |
iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% |
iShares Nikkei 225® | -4.513% | -8.017% | 5.961% |
iShares S&P 500 | -2.607% | -4.265% | 21.865% |
According to BiotechBee what are the pros and cons of Cytomx Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cytomx Therapeutics Inc diskutieren
Buy mit Kursziel 4,0
In the thread Trading Cytomx Therapeutics Inc
Buy beendet
Current prediction by BiotechBee for Cytomx Therapeutics Inc
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€4.18
02.05.24
02.05.24
€50.00
28.06.26
28.06.26
-72.57%
05.08.24
05.08.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Cytomx Therapeutics Inc
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€1.73
05.01.23
05.01.23
€3.00
31.12.25
31.12.25
37.80%
06.01.23
06.01.23
Could be very worthwhile Investment >20% year